Teen dies after viral TikTok challenge; what is 'dusting' and how it causes sudden sniffing death
'Dusting' is a viral trend in which individuals inhale cleaning spray for a brief moment of intoxication.
Some trends often go viral, with many unassuming children jumping on the bandwagon in an attempt to gain popularity. Earlier, trends like the ' Blue Whale Challenge ' also went viral, which led to many children causing harm to themselves.
This week, Renna O'Rourke, a 19-year-old living in the United States, succumbed to sudden sniffing death syndrome after she participated in the challenge. She ordered a computer cleaning spray to her home and inhaled its contents. After battling for four days in the ICU, she passed away — never having regained consciousness.
Speaking to local media, her parents are now trying to raise awareness of such dangerous challenges that young people often participate in.
Her father, while speaking to 12 News, said that she often said 'I'm gonna be famous, Dad'. "Unfortunately, this is not under the most optimal of circumstances," he added.
Her parents have urged other parents to keep an eye on their children's online activities. They have even asked other guardians to be mindful of the things children keep in their room and have access to.
What is sudden sniffing death syndrome?
Sudden sniffing death syndrome occurs when a fatal cardiac event takes place after inhaling some substances, often inhalants.
Inhalants are chemical vapours found in common household products like glue, paint thinners, cleaning fluids, and even some types of gas.
Sometimes, when a person inhales such substances, they can experience various effects which includes heart arrhythmia (irregular heartbeat), that can cause sudden cardiac arrest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UAE Moments
3 hours ago
- UAE Moments
15 Foods That Can Harm Your Gut and Upset Digestion
15 Foods That Can Upset Your Stomach These troublesome foods are well-known for disturbing digestion, disrupting gut balance, sparking inflammation, and potentially contributing to weight gain. Care for Your Digestive Health It's easy to indulge in food choices that burden the stomach, like fast food and sugary treats. Surprisingly, even high-fiber foods that are otherwise healthy can strain your digestive system. Experts share important insights to keep your gut feeling good. 1. Simple Carbohydrates Not all carbs are the same. Complex carbohydrates, such as brown rice and sweet potatoes, can be healthy in moderation, says Dr. Aviva Romm, MD. However, refined carbs like white bread and pasta are problematic. These increase blood sugar and insulin levels, which over time may lead to obesity, inflammation, and insulin resistance. Common Examples: White pasta, donuts, bagels, muffins, and white bread. 2. Harmful Fats Fats like trans fats, saturated fats, and omega-6 fats encourage inflammation and promote weight gain in the midsection. While bans on trans fats have reduced their prevalence, processed foods may still contain these harmful elements. On the flip side, healthy fats such as those in olive oil and avocado support better metabolism and cell health. Common Examples: Fried snacks, packaged goods, high-fat meats, full-fat dairy, soybean and corn oils. 3. Processed Meats While flavorful, processed meats are loaded with saturated fats and lack fiber, making them hard to digest and potentially risky for cardiovascular health, explains registered dietitian Julie Rothenberg. Common Examples: Ground meats, deli slices, hot dogs. 4. Deep-Fried Foods The high-fat content of fried foods often leads to heartburn and acid reflux. These foods take longer to digest, creating additional strain on the stomach, according to Rothenberg. 5. Dairy Full of Lactose As lactase enzyme levels decline with age, consuming lactose-rich dairy can cause bloating and digestive discomfort. Common Examples: Milk, soft cheese, dairy desserts, traditional yogurt. 6. Excess Fructose High-fructose foods can result in bloating and gas, particularly for individuals with irritable bowel syndrome (IBS). Minimizing such foods can reduce gut issues. Common Examples: Honey, apples, mangoes, foods with high-fructose corn syrup. 7. Certain Fibers like Garlic and Onions Foods containing fructans, such as onions and garlic, may trigger gas and bloating for some people. Moderation can ease the discomfort. Common Examples: Onions, garlic, soybeans, artichokes, black beans. 8. Beans and Specific Nuts Beans, lentils, and certain nuts ferment in the gut during digestion, which can cause bloating and gas. Cutting back can help identify individual sensitivities. Common Examples: Lentils, cashews, pistachios. 9. Sweeteners Both natural and artificial sweeteners, including sugar alcohols like mannitol, may cause digestive distress such as gas and diarrhea. Common Examples: Sugar-free snacks, apples, nectarines, plums. 10. Low-Fat Food Options Despite their appeal, low-fat products may fail to satisfy hunger, prompting overeating. High-quality fats, such as those found in nuts or olive oil, support better satiety and overall function. 11. Alcohol Alcohol introduces empty calories while slowing down fat processing. Beers and sugary mixers further exacerbate inflammation and fat gain. Experts suggest simpler options like vodka with lime and soda water. 12. Drinks with Added Sugar Sodas and sugary juices that contain fructose are infamous for causing bloating. Carbonated drinks exacerbate the issue by introducing excess gas into the stomach. 13. Cakes and Baked Goods Packed with refined flour and sugar, pastries like muffins and scones can lead to imbalanced sugar levels, ultimately affecting weight and stomach health negatively. 14. Ready-Made Salad Mixes Though salads seem healthy, pre-packaged versions often include calorie-dense dressings and unhealthy toppings. Use olive oil and spices for a lighter touch. 15. Salty Processed Snacks
The National
5 hours ago
- The National
Scientists claim chances of curing baldness are growing
Benjamin Franklin, one of the founding fathers of the United States, famously joked that just two things in life were certain: death and taxes. For many men, however, a third inevitability looms – baldness. In June, Pelage Pharmaceuticals announced 'positive results' from Phase 2a clinical trials of PP405, a drug which aims to combat male-pattern baldness and the thinning of hair in women. The drug is designed to 'reactivate dormant hair follicle stem cells' and could become a 'first-in-class' treatment for men and women, Pelage Pharmaceuticals said in a statement. The treatment could 'go beyond slowing the hair loss process and directly drive hair follicle regeneration,' said Dr Christina Weng, the company's chief medical officer. 'This as a milestone that expands the possibilities of regenerative medicine,' she added. 'As we advance into the next stage of clinical development, our focus remains on delivering a science-driven solution that works for everyone.' Trial results show encouraging signs The phase 2a trials involved 78 participants, both men and women – with each person applying the drug or a placebo to their scalp once a day for four weeks. According to the results published by the company, four weeks after the treatment finished, an increase in hair density of 20 per cent or more was seen in almost one third of men who had a greater degree of hair loss. No improvement was observed in the placebo group. Pelage Pharmaceuticals says what is particularly significant is the drug's apparent ability to kick-start hair growth in follicles where no hair was previously present. A new approach to hair regeneration PP405 has been developed by researchers at the University of California, Los Angeles (UCLA), and targets a series of chemical reactions in cells. Male-pattern baldness is largely caused by genes, although environmental factors also play a role. In some men it begins in their late teens, with rates increasing with age. A US study found that 16 per cent of men aged 18 to 29 had 'moderate to extensive' hair loss, while among 40-somethings the figure was 53 per cent. Over their lifetime, 80 per cent of men will experience hair loss. Also, about 40 per cent of women will be affected by a thinning of their hair cover. Dr Bharat Pankhania, a senior clinical lecturer at the University of Exeter Medical School, said that with respect to medication, 'some progress' had been made with male-pattern baldness. 'It's inducing the hair follicles to be stimulated to wake up and start doing things they used to do once upon a time,' he said. A true cure, however, remains elusive. Indeed a 2023 paper in Trends in Biotechnology said that the most effective treatment remained a hair transplant. This paper noted that 'the needs and expectations of patients' were typically not met by current drug treatments, which were often expensive and had limited effectiveness. According to the study, only two drugs approved by the US Food and Drug Administration have been marketed as treatments following four decades of research – and these were branded as being only 'marginally effective'. A lucrative market driving innovation According to figures quoted in the Trends in Biotechnology paper, the global alopecia market was worth $7.6 billion in 2020, and by 2028 is likely to reach $13 billion. Some estimates have put the sector's value as being even higher. 'Because it's a huge market there's a lot of research to find a solution,' Dr Pankhania said. 'I remain optimistic, just as I remain optimistic with the management of [other conditions including] sickle cell anaemia. There's a demand.' While PP405 has sparked many headlines, there are many other strands of research aimed at gaining a better understanding of male-pattern baldness in the hope of finding a cure. Much of this centres on the genetic basis for the condition. Research by the University of Bonn and other institutions in Germany, published in 2023, found a link between rare variants of five genes and male-pattern baldness. The results, the university said when its findings were released, could lead to improved treatments. So for those whose hair is thinning or has almost completely gone, there are causes for optimism – assuming, of course, that they feel that their baldness needs to be cured.
Arabian Business
7 hours ago
- Arabian Business
UnitedHealth stock soars after Buffett's Berkshire buys 5.04mn shares
Call it the 'Oracle of Omaha' touch. Shares of the beleaguered UnitedHealth Group rose by nearly 12 per cent to over US$300 on Friday after Warren Buffett's Berkshire Hathaway revealed that it bought 5.04 million shares worth US$1.57 billion in the insurance company. It was a typical Buffett move, buying into a company when others sold. The shares were trading at US$630.73 on November 11 but had fallen to as low as US$234.6 on 1 August this year. UnitedHealth shares closed Thursday at US$271.49. Valued at $246 billion by market cap, it maintains its position as America's largest health insurer. Despite the headwinds, the company has maintained its quarterly dividend of US$2.21 per share. On Friday, the company experienced its best daily performance since March 2020, ending the day at US$304.01 after reaching a day high of US$310.3. According to a filing on Thursday. Berkshire Hathaway also sold its US$1 billion stake in T-Mobile US during the period, completely exiting the telecommunications operator. Buffett's company again trimmed its holdings in Apple and Bank of America. It sold 20 million shares of Apple during the period. Berkshire's Apple stake remains its largest equity stake by market value, despite it falling by about US$9.2 billion in the three months ended June 30. The company also sold 26 million BofA shares, bringing its stake down to about 8 per cent. Last year, in December, UnitedHealth's Chief Executive, Brian Thompson, was shot to death in Manhattan after facing criticism, especially from student groups, for rejecting insurance claims. The company is currently facing a Justice Department investigation into its medicare billing practices. In April, the company reported earnings below Wall Street estimates for the first time in more than a decade, sending the stock price plummeting further. Berkshire tweaked its investment in US homebuilders, building its stake in Lennar Corp and selling shares of DR Horton Inc. The company also bought more shares of steel manufacturer Nucor. Those changes were omitted in a previous filing as the company requested confidentiality treatment from the SEC. Shares of Nucor jumped nearly 8 per cent in afterhours trading, while Lennar and DR Horton were up about 3 per cent each.
